Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, February 16, 2021
[ Tue, Feb 16th 2021
] - WOPRAI
[ Tue, Feb 16th 2021
] - WOPRAI
[ Tue, Feb 16th 2021
] - WOPRAI
[ Tue, Feb 16th 2021
] - WOPRAI
[ Tue, Feb 16th 2021
] - WOPRAI
[ Tue, Feb 16th 2021
] - WOPRAI
[ Tue, Feb 16th 2021
] - WOPRAI
[ Tue, Feb 16th 2021
] - WOPRAI
[ Tue, Feb 16th 2021
] - WOPRAI
[ Tue, Feb 16th 2021
] - WOPRAI
[ Tue, Feb 16th 2021
] - WOPRAI
[ Tue, Feb 16th 2021
] - WOPRAI
[ Tue, Feb 16th 2021
] - WOPRAI
[ Tue, Feb 16th 2021
] - WOPRAI
Mon, February 15, 2021
[ Mon, Feb 15th 2021
] - WOPRAI
Fri, February 12, 2021
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
Jonathan Aschoff Initiated (APDN) at Strong Buy and Held Target at $480 on, Feb 12th, 2021
Jonathan Aschoff of Roth Capital, Initiated "Applied DNA Sciences, Inc." (APDN) at Strong Buy and Held Target at $480 on, Feb 12th, 2021.
Jonathan has made no other calls on APDN in the last 4 months.
There is 1 other peer that has a rating on APDN. Out of the 1 peers that are also analyzing APDN, 0 agree with Jonathan's Rating of Hold.
This is the rating of the analyst that currently disagrees with Jonathan
- Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $280 on, Thursday, January 14th, 2021
